Whalesbook
Mukka Proteins Limited has reported its audited financial results for the fiscal year ended March 31, 2026. The company posted consolidated revenue of ₹1403.52 crore and a profit after tax of ₹57.09 crore. Alongside these results, the board approved significant strategic moves including a ₹75 crore Non-Convertible Debenture (NCD) raise and investments in new ventures aimed at growth and diversification.
Financial Results and Board Approvals
The company's Board of Directors convened on May 15, 2026, approving the audited financials for the fiscal year ending March 31, 2026. These include consolidated revenue of ₹1403.52 crore and a profit after tax of ₹57.09 crore. Standalone figures show revenue at ₹1184.95 crore with a profit of ₹42.41 crore. The board also greenlit raising up to ₹75 crore through NCDs and approved strategic investments in a domestic joint venture focused on waste treatment and an entity in Sri Lanka.
Strategic Significance
The substantial revenue reported highlights the company's market position. The planned NCD fundraising will provide crucial capital for ongoing operations and expansion projects. Investments in animal waste treatment and Sri Lankan marine products indicate a strategic push to broaden business areas and international presence.
Company Background
Mukka Proteins has established itself as a key player in India's fish meal and fish oil industry. Its successful IPO in February 2024, which raised ₹195 crore, provided capital for working capital, capital expenditure, and general corporate needs. The latest fundraising and expansion initiatives build upon this financial footing.
Future Outlook for Shareholders
For shareholders, these developments signal potential capital injection into growth projects. The company is broadening its scope into waste management and international markets, with new revenue streams anticipated from the JV and Sri Lankan ventures once operational. The NCD issuance will also adjust the company's debt profile.
Key Risks to Monitor
Key risks include the successful execution and timely completion of the new joint venture and Sri Lankan entity. The company also faces potential raw material price volatility for its core fish meal and fish oil products. Ensuring optimal returns from the deployed capital and managing competition in the marine products and feed ingredients sector are also crucial.
Competitive Landscape
Competitors in the animal feed sector include Avanti Feeds Ltd., known for shrimp feed and aquaculture products, and Godrej Agrovet Ltd., which has a diversified agribusiness including animal feed. Coastal Corporation Ltd. operates in seafood processing and aquaculture feed. Mukka Proteins' strategic move into waste treatment and international markets offers a distinct diversification approach compared to peers primarily focused on feed production.
Upcoming Milestones
Investors will be watching for the completion of the domestic joint venture ('MPL FC HRC JV') by its July 31, 2026 deadline and the establishment of 'Lanka Bio Proteins Private Limited' in Sri Lanka by December 31, 2026. The successful execution of the ₹75 crore NCD issuance and the performance and revenue generation from these new business segments will also be key indicators. Market reaction and any subsequent management announcements will be closely monitored.